Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Statistics
Share Statistics
Abeona Therapeutics has 48.53M shares outstanding. The number of shares has increased by 18.48% in one year.
Shares Outstanding | 48.53M |
Shares Change (YoY) | 18.48% |
Shares Change (QoQ) | 11.65% |
Owned by Institutions (%) | 0% |
Shares Floating | 43.12M |
Failed to Deliver (FTD) Shares | 2.96K |
FTD / Avg. Volume | 0.61% |
Short Selling Information
The latest short interest is 2.21M, so 4.56% of the outstanding shares have been sold short.
Short Interest | 2.21M |
Short % of Shares Out | 4.56% |
Short % of Float | 4.78% |
Short Ratio (days to cover) | 4.2 |
Valuation Ratios
The PE ratio is -3.59 and the forward PE ratio is -48.35. Abeona Therapeutics's PEG ratio is 0.09.
PE Ratio | -3.59 |
Forward PE | -48.35 |
PS Ratio | 0 |
Forward PS | 0.6 |
PB Ratio | 5.19 |
P/FCF Ratio | -3.91 |
PEG Ratio | 0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Abeona Therapeutics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.52.
Current Ratio | 6.08 |
Quick Ratio | 6.08 |
Debt / Equity | 0.52 |
Debt / EBITDA | -0.36 |
Debt / FCF | -0.39 |
Interest Coverage | 15.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-468.63K |
Employee Count | 136 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -35.86% in the last 52 weeks. The beta is 1.7, so Abeona Therapeutics's price volatility has been higher than the market average.
Beta | 1.7 |
52-Week Price Change | -35.86% |
50-Day Moving Average | 5.19 |
200-Day Moving Average | 5.55 |
Relative Strength Index (RSI) | 49.29 |
Average Volume (20 Days) | 482.91K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -64.21M |
Net Income | -63.73M |
EBITDA | -64.21M |
EBIT | -67.94M |
Earnings Per Share (EPS) | -1.55 |
Balance Sheet
The company has 23.36M in cash and 23.05M in debt, giving a net cash position of 309K.
Cash & Cash Equivalents | 23.36M |
Total Debt | 23.05M |
Net Cash | 309K |
Retained Earnings | -813.26M |
Total Assets | 108.93M |
Working Capital | 84.27M |
Cash Flow
In the last 12 months, operating cash flow was -56.02M and capital expenditures -2.45M, giving a free cash flow of -58.46M.
Operating Cash Flow | -56.02M |
Capital Expenditures | -2.45M |
Free Cash Flow | -58.46M |
FCF Per Share | -1.42 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for ABEO is $17, which is 252% higher than the current price. The consensus rating is "Buy".
Price Target | $17 |
Price Target Difference | 252% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 5, 2022. It was a backward split with a ratio of 1:25.
Last Split Date | Jul 5, 2022 |
Split Type | backward |
Split Ratio | 1:25 |
Scores
Altman Z-Score | -9.09 |
Piotroski F-Score | 2 |